Procter & Gamble Company (the) · NYSE:PG

Procter & Gamble Company (the) — Barclays Back to School Consumer Conference 2012

74 slides from Procter & Gamble Company (the)'s conference presentation, Sep 6, 2012

  1. Slide 1: Barclays Back to School Consumer Conference

    Barclays Back to School Consumer Conference September 6, 2012

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain statements in this release or presentation, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based,

  3. Slide 3: Regulations FD and G Disclosures

    Regulations FD and G Disclosures For a full reconciliation, please visit: www.pg.com/investors

  4. Slide 4: Barclays Back to School Consumer Conference

    Barclays Back to School Consumer Conference September 6, 2012

  5. Slide 5: Jon Moeller, Chief Financial Officer

    Jon Moeller Chief Financial Officer

  6. Slide 6: Agenda

    Agenda • Recent Results & Outlook • Growth & Productivity Strategy • Q&A

  7. Slide 7: Past Year Results FY'10 - FY'12

    Past 3 Year Results FY’10 - FY’12 • ~4% average Organic Sales growth • ~4% average Core EPS growth • Solid free cash flow productivity • ~9% average Dividend increase • Strong levels of cash returned to shareholders

  8. Slide 8: Recent Results: Organic Sales Growth

    Recent Results Organic Sales Growth Past 3 year CAGR = 4% 11 consecutive quarters in range of 3% to 5%

  9. Slide 9: Recent Results: Pricing Trend

    +5% Recent Results Pricing Trend +4% +1% FY’13 - 8 th consecutive year of positive pricing contribution to sales growth $3.5 billion

  10. Slide 10: Recent Results: Pricing vs. Competition

    Recent Results Pricing vs. Competition in April - June Quarter Apr-June Jan-Mar P&G 4 5 Unilever 3.5 4.7 Colgate 3.5 3.5 Kimberly Clark 2 3 Clorox 5 4

  11. Slide 11: Organic Sales Growth led by Developing Markets

    Recent Results Organic Sales Growth led by Developing Markets Developing Developed +11%

  12. Slide 12: Sales Growth - BRIC Markets

    Recent Results Sales Growth - BRIC Markets 14% CAGR for the Past 3 Years 2012: China +16%; Brazil + 15%; India +16% & Russia +11%

  13. Slide 13: P&G Asia Sales Growth

    1991 2001 2012 $15.0B ~$1.5B $4.0B Recent Results P&G Asia Sales Growth Asia Sales up 10X

  14. Slide 14: P&G Latin America Sales Growth

    1991 2001 2012 $8.3B $1.0B $2.9B Recent Results P&G Latin America Sales Growth Latin America Sales up 8X

  15. Slide 15: P&G CEEMEA Sales Growth

    1991 2001 2012 $12.1B <$1.0B ~$2.5B Recent Results P&G Central & Eastern Europe, Middle East & Africa Sales Growth CEEMEA Sales up 12X

  16. Slide 16: % of Sales Holding or Growing Value Share

    Market share data is value basis, constant currency. Recent Results % of Sales Holding or Growing Value Share

  17. Slide 17: Recent Results: Core EPS Growth

    Recent Results Core EPS Growth -1% 5% * History adjusted for Snacks moving to Discontinued Operations. 7% ~4%average EPS growth

  18. Slide 18: Adjusted Free Cash Flow Productivity

    Recent Results Adjusted Free Cash Flow Productivity 90%, $9.8 billion Consistently Delivering 90% Cash Productivity Target

  19. Slide 19: Returning Value to Shareholders

    Recent Results Returning Value to Shareholders $ billions FY ‘12 Past 10 Years Dividends $6 $42 Share Repurchase 4 46 * Value to Shareholders $10 $88 Shareholder Yield** % of market cap 5.5%

  20. Slide 20: FY 2013 Guidance

    FY 2013 Guidance FY ‘13 & Q1 Guidance - Unchanged FY ‘13 Q1 Q2 2H Organic Sales Growth +2% to +4% 0% to +2% +3% to +4% +3% to +4% FX 0% to -2% -6% All-In Sales Growth 0% to -2% -4% to -6% Core EPS $3.80 to $4.00 $0.91 to $0.97 Core EPS Growth -1% to +4% -10% to -4% +1% to +6% +1% to +6% Potential Ri

  21. Slide 21: FY 2013 Guidance: Cash Generation and Usage Assumptions

    Free Cash Flow Productivity: ~ 90% Capital Spending, % Sales: ~5.5% Dividends: $6bn+ Share Repurchase: $4bn Value to Shareholders: $10bn+ Shareholder Yield: ~5.5% FY 2013 Guidance Cash Generation and Usage Assumptions

  22. Slide 22: Agenda

    Agenda • Recent Results & Outlook • Growth & Productivity Strategy • Developing Markets - Maintain the Momentum • Strengthen the Core - 40/20/10 • Productivity Plans and Progress • Q&A

  23. Slide 23: Developing Markets: Market Growth Potential

    Developing Markets Market Growth Potential • Population is forecast to grow 800 million people with ~95% from developing markets

  24. Slide 24: Developing Markets: P&G Sales Progression 2000 to 2012

    80% 62% 20% 38% Developed Developing $32 bn $8 bn Developing Markets P&G Sales Progression: 2000 to 2012 12% Sales Growth CAGR over 12 Years

  25. Slide 25: Developing Markets: Current Footprint & Sales

    Developing Markets Current Footprint & Developing Market Sales P&G Unilever L’Oreal Colgate $32B $22B $9B $9B Developed Developing Developing Market Sales

  26. Slide 26: Developing Markets Expansions - Oral Care

    Developing Markets Expansions - Oral Care

  27. Slide 27: Developing Markets Expansions - Eastern Europe Vicks

    Developing Markets Expansions - Eastern Europe Vicks

  28. Slide 28: Developing Markets Expansions - Africa Safeguard

    Developing Markets Expansions - Africa Safeguard

  29. Slide 29: Brazil Hair Care Market Growth

    2.8% P&G Value Share JF’08 10% P&G Value Share MJ ‘12 *Constant FX @ 1.76 Developing Markets Brazil Hair Care Market Growth

  30. Slide 30: China Baby Care Market Growth

    28.7% P&G Value Share FY08/09 30.2% P&G Value Share FY11/12 Developing Markets China Baby Care Market Growth *Constant FX

  31. Slide 31: India Blades & Razors Market Growth

    38.2% P&G Value Share FY 08 48.7% P&G Value Share FY12 *Constant FX Developing Markets India Blades & Razors Market Growth

  32. Slide 32: India Diapers Market Growth

    36.1% P&G Value Share FY 08 56.5% P&G Value Share FY12 *Constant FX Developing Markets India Diapers Market Growth

  33. Slide 33: Developing Markets: Brazil Hair Care

    Developing Markets Brazil Hair Care Sales per Unit FY 09 179 Index Eee 121 Index @ = EA nit Treatments 400ml Cond Pantene 200m! @ = Volume Share *All numbers at constant FX (at 2.03) Sh Pantene 200m :up+ 42% FY 13E 307 Index 197 Index C394) 253 Index 138 Index @ % 48% © EA Ampoules (Pack with 3) me

  34. Slide 34: Developing Markets: India Blades & Razors Care

    Developing Markets India Blades & Razors Care Sales per Unit: up +25% FY08 FY12 2000 Index 475 Index 595 Index 900Index 450 Index eee @ @ 116 Index @ 46% 44% Shave Shave 28% Preps = Disposables Disposables Preps Systems Double- Systems Double- Edge Edge 3000 Index = % of Volume *All numbers at const

  35. Slide 35: Developing Markets: Russia Feminine Care

    Developing Markets Russia Feminine Care Sales per unit up +9% FY 11 FY12 “All numbers at constant FX

  36. Slide 36: Developing Markets: China Baby Care

    Developing Markets China Baby Care Sales per unit: +8% FY10 443 Index 200 Index ap pa Pampers e e Be ce Seem Mid Tier Premium Tier tx) = Volume split% Base 38% Value Tier Value Tier FY13E 192 Index 158 Index > ‘e =i Tier 101

  37. Slide 37: BRIC Sales per Unit Growth

    Developing Markets BRIC Sales per Unit Growth + Double- Digit Sales per unit Increase vs. FY 11

  38. Slide 38: Localized Manufacturing

    Developing Markets Localized Manufacturing FY ’13 & ‘14 Start-ups New Plant Start-ups • China • Brazil • Nigeria • Indonesia New Category Start-ups • Poland • Venezuela • India Capacity Increases • India • EMEA - multiple sites

  39. Slide 39: Localized Manufacturing: Margin Increases

    Developing Markets Localized Manufacturing • Oral Care (Brazil) • +4% increase in BT margin • Baby Care (Nigeria) • >10% increase in BT margin

  40. Slide 40: Developing Markets Scale Driven Efficiencies

    Developing Markets Scale Driven Efficiencies

  41. Slide 41: Developing Markets Profit Growth

    Developing Markets Profit Growth FY 2013 Expectation 9 of 10 Top Developing Markets Profitable Top 10 Developing Market After Tax Profit +40%* * Based on mid-August fx rates

  42. Slide 42: Developing Markets Per Capita Spending

    Developing Markets Per Capita Spending $94 $64 $40 $21 $19 $11 $5 $2 $1 $1 >$50 billion sales opportunity

  43. Slide 43: Agenda

    Agenda • Recent Results & Outlook • Growth & Productivity Strategy • Developing Markets - Maintain the Momentum • Strengthen the Core - 40/20/10 • Productivity Plans and Progress • Q&A

  44. Slide 44: Strengthen the Core: Top 40 Category/Country Businesses

    • Products with superior value and performance • Competitive pricing • Strong innovation • Effective communication to consumers • Sufficient marketing support Strengthen the Core Top 40 Category/Country Businesses

  45. Slide 45: Innovation Fabric Care: Tide Pods

    Innovation Fabric Care “One Tide POD outperforms the next 6 competitors… combined !”

  46. Slide 46: Innovation Fabric Care: Tide Pods Value Equation

    Index vs. Tide Liquids Index vs. Tide PODS Index Same Brand Unit Dose vs. Liquid Base 120 55 150 61 170 Innovation Fabric Care Tide PODS… • Reframes category value equation • Provides platform for future innovation and growth

  47. Slide 47: Innovation Fabric Care

    Innovation Fabric Care “Keeps clothes fresh in your closet for up to 12 weeks - until you wear them.”

  48. Slide 48: Innovation Personal Health Care

    Innovation Personal Health Care “Not for colds, not for pain, JUST FOR SLEEP”

  49. Slide 49: Innovation Dish Care

    Innovation Dish Care “Even removes hidden grease from your dishwasher parts ”

  50. Slide 50: Innovation Batteries

    Innovation Batteries “ Guaranteed for 10-Years in Storage”

  51. Slide 51: Innovation Family Care

    Innovation Family Care “ Use 4 times less vs. the leading value brand”

  52. Slide 52: Innovation Oral Care

    DEFENDS AGAINST THE CONDITIONS PEOPLE OVER 50 EXPERIENCE DER, INFLAMED GUMS Cox? PLAQUE PRO-HEALTH + BAD BREATH FORLIFE ‘ = Ma ciate Govpihion yoo as PRO-HEALTH Cera? + Oral B) FOR LIFE

  53. Slide 53: Innovation Baby Care

    Innovation Baby Care “Up to 12 hours of protection for beautiful mornings ”

  54. Slide 54: Innovation Prestige Fragrances

    Innovation Prestige Fragrances

  55. Slide 55: Innovation Prestige Skin Care

    Innovation Prestige Skin Care

  56. Slide 56: Innovation Skin Care

    Innovation Skin Care 1 st Mass Skin Care product delivering Anti-Aging benefits & BB type instant coverage

  57. Slide 57: Innovation Skin Care

    Innovation Skin Care 1 st Mass total eye care product - designed to give women younger, brighter looking eyes in just 1 week

  58. Slide 58: Innovation Skin Care

    Innovation Skin Care

  59. Slide 59: Innovation Skin Care

    Innovation Skin Care

  60. Slide 60: Innovation Hair Care

    Innovation Hair Care up to 100% Flake Free Leaves hair up to10x stronger* 7 Benefits of cleaning * Strength against damage vs. non-conditioning shampoo.

  61. Slide 61: Pantene

    @ PMT paNTENE | PANTENE PANTENE ce

  62. Slide 62: Innovation Hair Care: Vertical Portfolio Expansion in U.S.

    Innovation Hair Care Vertical Portfolio Expansion in U.S. New Super Premium Line 200 - 250 Price Index Pantene Base

  63. Slide 63: Agenda

    Agenda • Recent Results & Outlook • Growth & Productivity Strategy • Developing Markets - Maintain the Momentum • Strengthen the Core - 40/20/10 • Productivity Plans and Progress • Q&A

  64. Slide 64: Productivity Plans and Progress

    Productivity Plans and Progress • Strategic imperative Non-manufacturing Overhead Billion $ Cost of Goods Marketing Efficiencies $3B $1B $6B

  65. Slide 65: Non-Manufacturing Staffing

    Productivity Plans and Progress Non-Manufacturing Staffing Original Plan FY ’12** FY ’13 FY ’14 Sub- Total FY’15 & FY’16 Total % Reduction* ~3% ~7% ++ ~10% ++ >10% Positions 1,600 4,100 ++ 5,700 ++ >5,700 Savings, $MM $240 $560 $800 $200 ~$1,000

  66. Slide 66: Non-Manufacturing Staffing: Original vs. Updated Plan

    Original Plan FY ’12** FY ’13 FY ’14 Sub- Total FY’15 & FY’16 Total % Reduction* ~3% ~7% ++ ~10% ++ >10% Positions 1,600 4,100 ++ 5,700 ++ >5,700 Savings, $MM $240 $560 $800 $200 ~$1,000 Updated Plan % Reduction* 5.3% 4.7% ++ ~10% ++ >10% Positions 3,000 2,700 ++ 5,700 ++ >5,700 Savings, $MM $50 $40

  67. Slide 67: Core SG&A Overhead - 2012 Building Blocks

    Productivity Plans and Progress Core SG&A Overhead - 2012 Building Blocks % of Sales Reported SG&A* 33.5% Less: Advertising (11.2) Less: Other Marketing (5.3) Less: Non-Core Restructuring (0.6) Less: Goodwill & Intangible Impairments (1.9) Core SG&A 14.4% * Excludes Transportation & Warehousing

  68. Slide 68: Core SG&A Overhead Benchmarking

    Productivity Plans and Progress Core SG&A Overhead* Benchmarking * Excludes Transportation & Warehousing, Marketing and Non-Core Items

  69. Slide 69: P&G Business Segment Composition

    Productivity Plans and Progress P&G Business Segment Composition Sales* $Bn FY’12 % Mix Beauty $20 24% Grooming 8 10% Fabric Care & Home Care 27 32% Baby Care & Family Care 16 19% Health Care 12 15% Total $83.7 100%

  70. Slide 70: Core SG&A Overhead Competitive Benchmarks

    Productivity Plans and Progress Core SG&A Overhead Competitive Benchmarks Core SG&A Overhead FY'12 % Mix Benchmark Companies Beauty 24% 20% Beiersdorf, L'Oreal, Unilever Grooming 10% 19% ENR, Beiersdorf Fabric Care & Home Care 32% 10% CHD, CLX, Henkel, Reckitt, Unilever Baby Care & Family Care 19% 1

  71. Slide 71: P&G Core SG&A Overhead Objective

    Productivity Plans and Progress P&G Core SG&A Overhead Objective 12% - 13% Core SG&A Overhead FY'12 Benchmark Target Beauty 20% 17% - 18% Grooming 19% 16% - 17% Fabric Care & Home Care 10% ~9% Baby Care & Family Care 10% ~9% Health Care 15% 13% - 14% Total 14.4% ~14% 12% - 13%

  72. Slide 72: Accountability

    Accountability Simplified set of 7 performance metrics that tie directly to shareholder value creation: 1. Volume 2. Sales 3. Market Share 4. Operating Profit 5. Productivity 6. Cash Flow 7. Internal Controls

  73. Slide 73: Path to Target EPS Growth Range

    Path to Target EPS Growth Range High-Single Digits to Low-Double Digits EPS Growth Organic sales growth at market level (fully loaded, i.e. no leverage) 4% Cost savings at full run rate and leverage; get range of half-to-all of projected savings 6% to 11% Share repurchase 2% High-side Potential ~12%

  74. Slide 74: Reg G Reconciliation of Non-GAAP measures

    The Procter & Gamble Company: Reg G Reconciliation of Non-GAAP measures In accordance with the SEC’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings call and slides with the reconciliation to the most closely related GAAP measure. The measures provided

PROCTER & GAMBLE — Barclays Back to School Consumer Conference 2012 on 6ix